Although a known target of p53, Glipr1 also has a p53-independent tumor suppressor function, as its misregulation is associated to colorectal cancer, myeloma and prostate cancer (Aytekin et al., 2010; Li et al., 2008; Tam et al., 2010). Here, TP53 is linked to prostate carcinoma.